EUVIMEDEUVIMED entdecken
Crossref

Columbianadin Ameliorate Osteoporosis Against Glucocorticoid Induced Osteoporosis in Rats via Alteration of RANK/RANKL/OPG Signaling Pathway

Songbo Mao, Chuntao Xu, Lin Zou iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Songbo Mao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Orthepadic Department, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Osteoporosis, Glucocorticoids, RANK Ligand, Osteoprotegerin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: The current research was funded by Project of Shandong Provincial Health Science and Technology Development (202104071089)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteoporosis is a condition in where bones gradually become thin and weak, making them more susceptible to fractures. Columbianadin has showed potential anti‐inflammatory and antioxidant effect. In this experimental study, anti‐osteoporosis effect of Columbianadin against glucocorticoid induced osteoporosis in rats.

Methods

In this study, Sprague Dawley (SD) rats were used and osteoporosis was induced by administering dexamethasone (DEX) at a dosage of 2.5 mg/kg/day. Following induction, the rats were treated orally with different doses of columbianadin. The body weight, organ (femoral, vagina and uterus) weights were measured. The bone parameters, antioxidant, cytokines, hormones were evaluated.

Results

Columbianadin improved body weight and altered the organ weight such as femoral, vagina and uterus. It also modulated the various bone related parameters including bone mineral density (BMD), tissue mineral density (TMD), bone mineral content (BMC), tissue mineral content (TMC); bone parameters like tartrate‐resistant acid phosphatase (TRAP), β ‐C‐terminal telopeptide of type I collagen (β‐CTX), osteocalcin (OC), bone gla protein (BGP), acid phosphatase (ACP), alkaline phosphatase (ALP). Additionally, Columbianadin influence hormone level such as estradiol (E 2 ) and parathyroid hormone (PTH) and enhanced antioxidant defense via modulating glutathione peroxidase (GPx), thiobarbituric acid reactive substances (TBARS), catalase (CAT), superoxide dismutase (SOD), glutathione (GSH). It also regulated the cytokines parameters like tumor necrosis factor‐ α (TNF‐α), interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), insulin‐like growth factor (IGF), transforming growth factor‐β (TGF‐β). Furthermore, columbianadin modulated the levels of receptor activator of nuclear factor‐κB ligand (RANKL), osteoprotegerin (OPG) and OPG/RANKL ratio. Columbianadin also altered mRNA expression of ALP, OPN, runt‐related transcription factor 2 (RunX2), OCN, bone morphogenetic proteins (BMP)‐2, 4, 6, 7, 9, B‐cell lymphoma 2 (BcL‐2), B‐cell lymphoma‐extra‐large (BcLxL), Inhibitor of Apoptosis Protein (IAP) 1, 2, X‐linked Inhibitor of apoptosis Protein (XIAP), caspase‐3,6,7,9, respectively.

Conclusion

The finding of the study clearly demonstrates that columbianadin exerts a significant antiosteoporosis effect against glucocorticoid‐induced osteoporosis in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisGlucocorticoidsRANK LigandOsteoprotegerinSignal TransductionReceptor Activator of Nuclear Factor-kappa BIsoflavonesAnimalsRats, Sprague-DawleyRatsFemaleBone DensityDexamethasone

Stichwörter der Autor:innen

AntioxidantBone parametersInflammationOsteoporosis

Substanzen

GlucocorticoidsRANK LigandOsteoprotegerinReceptor Activator of Nuclear Factor-kappa BTnfrsf11b protein, ratIsoflavonesDexamethasone

Autor:innen und Institutionen

  • Orthepadic Department, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong, China.

ORCID-Profile: Lin Zou

Förderung

  • The current research was funded by Project of Shandong Provincial Health Science and Technology Development (202104071089).

Zitieren

APA

Mao, S., Xu, C., & Zou, L. (2025). Columbianadin Ameliorate Osteoporosis Against Glucocorticoid Induced Osteoporosis in Rats via Alteration of RANK/RANKL/OPG Signaling Pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70432

Vancouver

Mao S, Xu C, Zou L. Columbianadin Ameliorate Osteoporosis Against Glucocorticoid Induced Osteoporosis in Rats via Alteration of RANK/RANKL/OPG Signaling Pathway. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70432

BibTeX
@article{Mao2025,
  author = {Mao, Songbo and Xu, Chuntao and Zou, Lin},
  title = {Columbianadin Ameliorate Osteoporosis Against Glucocorticoid Induced Osteoporosis in Rats via Alteration of RANK/RANKL/OPG Signaling Pathway},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70432}
}
Kostenlos starten →